<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02954809</url>
  </required_header>
  <id_info>
    <org_study_id>030-702786</org_study_id>
    <nct_id>NCT02954809</nct_id>
  </id_info>
  <brief_title>Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors</brief_title>
  <official_title>Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York at Buffalo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oncology Nursing Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>State University of New York at Buffalo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of morning bright light therapy on
      fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized controlled trial to test the effects of morning bright light therapy on fatigue,
      sleep disturbances, and circadian activity rhythms in lung cancer survivors.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in fatigue symptoms with Fatigue Severity Index from pre-test to post-test</measure>
    <time_frame>5 weeks</time_frame>
    <description>Comparison of fatigue severity from pre-test to post-test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in sleep quality with the Pittsburgh Sleep Quality Index from pre-test to post-test</measure>
    <time_frame>5 Weeks</time_frame>
    <description>Comparison of Sleep Quality from pre-test to post-test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in insomnia with Insomnia Severity Index from pre-test to post-test</measure>
    <time_frame>5 weeks</time_frame>
    <description>Comparison of insomnia from pre-test to post-test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in circadian activity rhythms with actigraphy from pre-test to post-test</measure>
    <time_frame>5 weeks</time_frame>
    <description>Circadian Activity Rhythms will be assessed with actigraphy during the 5-week time frame.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessement of chronotype with the Morningness versus Eveningness Questionnaire</measure>
    <time_frame>1 day</time_frame>
    <description>Chronotype will be assessed at baseline for a descriptive analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Environmental light with actigraphy (Actiwatch Spectrum Respironics)</measure>
    <time_frame>5 weeks</time_frame>
    <description>Exposure to environmental light will be assessed at pre-test, intervention and post-test for a descriptive analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Quality of Life with theFunctional Assessment of Cancer Therapy - Lung</measure>
    <time_frame>5 weeks</time_frame>
    <description>Quality of Life will be assessed before, during, and after the intervention.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Assessment of Visual acuity with the Snellen visual acuity chart</measure>
    <time_frame>5 weeks</time_frame>
    <description>Visual acuity data will be collected and save for safety purposes only at pre-test and post-test.</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessment of daytime sleepiness with the Epworth Sleepiness Scale</measure>
    <time_frame>5 weeks</time_frame>
    <description>Daytime Sleepiness will be assessed for safety purposes only at pre-test, intervention and post-test. Individuals with high daytime sleepiness and/or at risk of falling asleep while driving or performing hazardous activities will be referred out to primary care</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">14</enrollment>
  <condition>Fatigue</condition>
  <condition>Sleep Disturbance</condition>
  <condition>Circadian Dysregulation</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attention Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exposure to dim light delivered with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Morning bright light therapy</intervention_name>
    <description>Exposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dim light</intervention_name>
    <description>Exposure to dim light with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.</description>
    <arm_group_label>Attention Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage I-III Non-small cell lung cancer survivors

          -  Must be at &gt;6-weeks and &lt; 3 years post-surgical resection

          -  Must have diagnosis fatigue and/or sleep disturbances

        Exclusion Criteria:

          -  Individuals clinically unstable.

          -  Mania, Bipolar disease or seizure disorder

          -  Macular degeneration or glaucoma.

          -  Currently receiving chemotherapy or radiation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Carleara Ferreira da Rosa Silva, MS, RN</last_name>
    <phone>716-829-3494</phone>
    <email>carleara@buffalo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Grace E Dean, PhD</last_name>
    <phone>716-829-3235</phone>
    <email>gdean@buffalo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SUNY University at Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carleara Ferreira da Rosa Silva, MS, RN</last_name>
      <phone>716-829-3494</phone>
      <email>carleara@buffalo.edu</email>
    </contact>
    <investigator>
      <last_name>Carleara Ferreira da Rosa Silva, MS, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grace E Dean, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dean GE, Redeker NS, Wang YJ, Rogers AE, Dickerson SS, Steinbrenner LM, Gooneratne NS. Sleep, mood, and quality of life in patients receiving treatment for lung cancer. Oncol Nurs Forum. 2013 Sep;40(5):441-51. doi: 10.1188/13.ONF.441-451.</citation>
    <PMID>23989018</PMID>
  </reference>
  <reference>
    <citation>Ancoli-Israel S, Rissling M, Neikrug A, Trofimenko V, Natarajan L, Parker BA, Lawton S, Desan P, Liu L. Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support Care Cancer. 2012 Jun;20(6):1211-9. doi: 10.1007/s00520-011-1203-z. Epub 2011 Jun 11.</citation>
    <PMID>21660669</PMID>
  </reference>
  <reference>
    <citation>Jeste N, Liu L, Rissling M, Trofimenko V, Natarajan L, Parker BA, Ancoli-Israel S. Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy. Qual Life Res. 2013 Aug;22(6):1239-44. doi: 10.1007/s11136-012-0243-2. Epub 2012 Aug 3.</citation>
    <PMID>22865153</PMID>
  </reference>
  <reference>
    <citation>Ancoli-Israel S, Liu L, Rissling M, Natarajan L, Neikrug AB, Palmer BW, Mills PJ, Parker BA, Sadler GR, Maglione J. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer. 2014 Sep;22(9):2535-45. doi: 10.1007/s00520-014-2204-5. Epub 2014 Apr 15.</citation>
    <PMID>24733634</PMID>
  </reference>
  <reference>
    <citation>Redd WH, Valdimarsdottir H, Wu LM, Winkel G, Byrne EE, Beltre MA, Liebman ES, Erazo T, Hayes JA, Isola L, Scigliano E, Meschian Y, Lutgendorf S, Ancoli-Israel S. Systematic light exposure in the treatment of cancer-related fatigue: a preliminary study. Psychooncology. 2014 Dec;23(12):1431-4. doi: 10.1002/pon.3553. Epub 2014 May 2.</citation>
    <PMID>24798589</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2016</study_first_submitted>
  <study_first_submitted_qc>November 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2016</study_first_posted>
  <last_update_submitted>November 3, 2016</last_update_submitted>
  <last_update_submitted_qc>November 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fatigue</keyword>
  <keyword>sleep disturbances</keyword>
  <keyword>circadian activity rhythms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Chronobiology Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

